开始
PivotX

LXRX. Approved Drug. More coming.

做多
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)  
PivotX  
NASDAQ:LXRX   Lexicon Pharmaceuticals, Inc.
Trend Analysis Chart Patterns Wave Analysis
4
0
trendanalysis chartpattern waveanalysis
LXRX. Approved Drug. More drugs coming to market. Selling new drug starts in June.
High institutional value. High Insider Value. etc etc
Rocket is fueling.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。